TRINITY BIOTECH PLC(TRIB)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Limited institutional coverage
Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 26 institutional filers currently hold this stock.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
TRIB Stock Analysis & AI Quality Score
AI stock analysis and institutional research for TRINITY BIOTECH PLC (TRIB), a Healthcare sector company. TRIB is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 26 institutional filers currently hold this stock. Based on the latest XBRL financial filings (FY 2024), TRINITY BIOTECH PLC reports quarterly revenue of $61.6M, net income of $-31.2M. Top institutional holders of TRIB by reported 13-F value include Yorkville Advisors Global,, Williams & Novak,, Moss Adams Wealth Advisors, based on the most recent SEC filings. TRIB trades on the Nasdaq exchange and files with the SEC under CIK 888721. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TRIB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for TRINITY BIOTECH PLC directly from SEC EDGAR.
Revenue
FY 2024
$61.6M
Net Income
FY 2024
$-31.2M
AI Insight: TRIB Ratio Trends
No financial ratio data available for Trinity Biotech across all periods — insufficient information to assess operational performance trends.
• All key profitability and efficiency metrics missing across nine periods from Q4 2019 through Q4 2024.
⚠ Complete absence of ratio data prevents assessment of operational leverage, capital efficiency, or financial health trends.
Get alerted when TRIB's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for TRINITY BIOTECH PLC including:
Top Institutional Holders of TRIB
Yorkville Advisors Global, LP
$122.0K225,000 shWilliams & Novak, LLC
$64.4K107,643 shMoss Adams Wealth Advisors LLC
$13.9K25,666 shINSPIRION WEALTH ADVISORS, LLC
$13.6K25,000 shRAYMOND JAMES FINANCIAL INC
$11.0K20,319 shBECKER CAPITAL MANAGEMENT INC
$9.8K18,000 shRENAISSANCE TECHNOLOGIES LLC
$9.6K17,762 shGEODE CAPITAL MANAGEMENT, LLC
$9.0K16,642 shLPL Financial LLC
$8.2K15,036 shSUSQUEHANNA INTERNATIONAL GROUP, LLP
$7.7K14,300 sh
| Fund | Value | Shares |
|---|---|---|
| Yorkville Advisors Global, LP | $122.0K | 225,000 |
| Williams & Novak, LLC | $64.4K | 107,643 |
| Moss Adams Wealth Advisors LLC | $13.9K | 25,666 |
| INSPIRION WEALTH ADVISORS, LLC | $13.6K | 25,000 |
| RAYMOND JAMES FINANCIAL INC | $11.0K | 20,319 |
| BECKER CAPITAL MANAGEMENT INC | $9.8K | 18,000 |
| RENAISSANCE TECHNOLOGIES LLC | $9.6K | 17,762 |
| GEODE CAPITAL MANAGEMENT, LLC | $9.0K | 16,642 |
| LPL Financial LLC | $8.2K | 15,036 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7.7K | 14,300 |
More Healthcare Companies
View all Healthcare →Put TRIB on your watchlist
Track score changes the day TRINITY BIOTECH PLC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is TRIB a good stock to buy?
13F Pro's AI-powered analysis of TRINITY BIOTECH PLC (TRIB) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for TRIB are available on the TRIB stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own TRIB?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling TRIB. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of TRINITY BIOTECH PLC's investment landscape.